In 2023, the trade exchange (includes international purchases and sales) of Antibiotics was US$266M.
In 2023, the states with the most international sales in Antibiotics were Estado de México (US$9.25M), Ciudad de México (US$320k), and Jalisco (US$70.7k).
The states with the most international purchases in 2023 were Jalisco (US$98.5M), Ciudad de México (US$54.4M), Estado de México (US$32.4M), Guanajuato (US$4.88M), and Coahuila de Zaragoza (US$2.23M).
In 2023, the main commercial destinations of Antibiotics were Spain (US$3.65M), Turkey (US$1.35M), Russia (US$702k), Brazil (US$609k), and Switzerland (US$574k).
The main commercial origins of Antibiotics in 2023 were China (US$114M), India (US$25.6M), Spain (US$18.3M), Italy (US$10.3M), and Ireland (US$5.48M).
In the global context, the main exporting countries of Antibiotics in 2022 were China (US$4.73B), India (US$885M), and Italy (US$833M). In the same year, the main importing countries of Antibiotics were India (US$1.57B), Italy (US$1.01B), and Germany (US$663M).